Home Hong Kong Healthcare Sector Rallies Mid-session with WuXi Biologics Leading Gains

Hong Kong Healthcare Sector Rallies Mid-session with WuXi Biologics Leading Gains

Aug 28, 2020 10:54 CST Updated 10:54
C-MER Medical

Ophthalmology Medical Chain Institution

CSPC

Innovative Drug Research and Development, Manufacturer

Yichang HEC Changjiang Pharmaceutical

Therapeutic Area Product Development and Manufacturing

Original Title: Hong Kong Stocks’ Healthcare Sector Strengthens During Trading Session, Led by WuXi Biologics Source: China Securities Journal · CS.com.cn

China Securities Journal News (Reporter Zhou Lulu): On the morning of August 28, the healthcare sector in Hong Kong stocks strengthened during trading. According to Wind data, as of 10:45, the healthcare sector rose by 1.80%, leading all Hang Seng industry sectors; within the sector, WuXi Biologics led the gains with a 5.51% increase, followed by C-MER Medical and CSPC.Tong Ren TangTechnology,HECPharmaceuticals rose by more than 2% on average.